Results 121 to 130 of about 88,639 (264)
Eurasian Journal of Medicine, 2019 Purpose: We investigated the role of factor V Leiden mutation in patients with retinal vein occlusion (RVO). Method: Factor V Leiden mutation was investigated in DNA obtained from the peripheral blood of 30 patients, diagnosed with retinal vein ...
Orhan Ateş, Orhan Baykal
doaj
Meta-Analysis of the Effect of Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide in Central Retinal Vein Occlusion [PDF]
, 2013 published_or_final_versio
Jin, ZY +4 more
core +1 more source
Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes [PDF]
, 2017 Purpose: Tranexamic acid (TXA) is a widely used antifibrinolytic agent that can also cause a decrease in vascular permeability. We hypothesized that TXA could improve macular edema (ME) that is caused by an increase in retinal vascular permeability.
Gosho Masahiko +7 more
core +3 more sources
Glia, 2019 The role of microglia in retinal inflammation is still ambiguous. Branch retinal vein occlusion initiates an inflammatory response whereby resident microglia cells are activated.
Joël Jovanovic +4 more
semanticscholar +1 more source
Cell Proliferation, EarlyView.In the oxygen‐induced retinopathy (OIR) mouse model, two distinct microglial subpopulations play opposing roles: highly glycolytic microglia (HGM) promote neovascular formation via Pkm2, while Mrc1/CD206‐positive phagocytosis‐associated microglia (PAM) facilitate its regression.
Yuan Ma +20 more
wiley +1 more source
Acute Central Retinal Vein Occlusion Secondary to Reactive Thrombocytosis after Splenectomy
Case Reports in Ophthalmological Medicine, 2014 The diagnosis and treatment of central retinal vein occlusion was reported in a young patient. Central retinal vein occlusion was probably related to secondary to reactive thrombocytosis after splenectomy.
Nursen Oncel Acir +2 more
doaj +1 more source
Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series [PDF]
, 2016 BACKGROUND: Although intravitreal injection of bevacizumab (IVB) is effective for macular edema in patients with branch retinal vein occlusion (BRVO), the changes of retinal hemodynamics remain unclear. We investigated retinal hemodynamic changes in BRVO
Hidetaka Noma +4 more
core +1 more source
Acta ophthalmologica, 2019 To characterize wide‐field optical coherence tomography angiography (OCTA) features of retinal nonperfusion in eyes with branch retinal vein occlusion (BRVO).
Akihiko Shiraki +9 more
semanticscholar +1 more source
Women in space: A review of known physiological adaptations and health perspectives
Experimental Physiology, EarlyView.Abstract Exposure to the spaceflight environment causes adaptations in most human physiological systems, many of which are thought to affect women differently from men. Since only 11.5% of astronauts worldwide have been female, these issues are largely understudied.
Millie Hughes‐Fulford +4 more
wiley +1 more source
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
BMC Ophthalmology, 2008 Background Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin®) treatment in patients with macular edema induced by branch retinal vein occlusion.
Barthelmes Daniel +5 more
doaj +1 more source